Slide 1: September 2013 Half Year Results
For personal use only September 2013 Half Year Results 25 November 2013 R I G H T S O L U T I O N S | R IGH T PART N ER
Slide 2: Important notice and disclaimer
Important notice and disclaimer For personal use only • This presentation has been prepared by ALS Limited, (ALS or the Company). It contains general information about the Company’s activities as at the date of the presentation. It is information given in summary form and does not purport to be comp
Slide 3: September 2013 Half Year Summary
September 2013 Half Year Summary H1 H2 H1 For personal use only half year FY13 FY13 FY14 ($mn) ($mn) ($mn) Revenue 813.6 685.7 744.7 EBITDA1 227.5 178.5 178.7 EBITDA1,2 from continuing operations 223.4 178.5 178.7 Gain on sale of discontinued 5.8 0.1 0 operations Impairment (6.1) (10.0) 0 EBIT1 200.
Slide 4: September 2013 Half Year Trend
September 2013 Half Year Trend Average USD:AUD (cents) For personal use only REVENUE 81 90 106 103 94 30th September 2013 8% 1000 250 $745mn EBITDA & NPAT (AUD million) 800 200 Revenue (AUD million) EBITDA 30th September 2013 21% 600 150 $179mn 400 100 NPAT 200 50 30th September 2013 28% 0 0 $98mn H
Slide 5: Operating Profit (EBIT) Diversification
Operating Profit (EBIT) Diversification For personal use only 200 150 EBIT ($ million) 100 50 0 Sep-04 Sep-05 Sep-06 Sep-07 Sep-08 Sep-09 Sep-10 Sep-11 Sep-12 Sep-13 Minerals Life Sciences Energy Industrial Reward + Chemical Note: Chemical Division (“Chemical”) divested during Sep-12 half year RIGHT
Slide 6: Strategy – Revenue Growth and Diversification
Strategy – Revenue Growth and Diversification 100% For personal use only Revenue per Half Year (USD$ million) 80% 60% Prorate Oil & Gas H1 FY14 40% 20% 0% Minerals Life Sciences Industrial Energy RIGHT SOLUTIONS | RIGHT PARTNER 6
Slide 7: Revenue – Market and Geography
Revenue – Market and Geography For personal use only Geochemistry Metallurgy M Inspection A Environmental R Food/Pharma K E Coal T Oil & Gas Asset Care Tribology H1 FY13 ($709mn) H1 FY14 ($685mn) Australasia G E North America O Asia G R South America A Africa P H Europe Y Middle East RIGHT SOLUTIONS
Slide 8: CAPEX and Depreciation
CAPEX and Depreciation For personal use only 25 CAPEX reduced in line with current operating environment 20 CAPEX (AUD$ million) 15 10 5 0 Jun-12 Sep-12 Dec-12 Mar-13 Jun-13 Sep-13 Quarter CAPEX (exl. property purchases) Depreciation & Amortisation 8 RIGHT SOLUTIONS | RIGHT PARTNER 8
Slide 9: Revenue Growth
Revenue Growth 900 For personal use only 800 ALS Group Revenue Growth 700 Revenue (AUD$mn) 600 • Organic Growth -16% 500 • Divestments -5% 400 300 • Acquired Growth +10% 200 • Currency Impact +3% 100 0 Reported Growth -8% Revenue Growth H1 FY14 Vs H1 FY13 Industrial Energy Life Sciences Minerals -40
Slide 10: Life Sciences Division
Life Sciences Division For personal use only H1 FY14 H1 FY13 Change Overview Revenue $272mn $225mn +21% • Organic revenue growth (9%) in Asia • Organic revenue growth (10%) in mainland EBITDA $69mn $58mn +19% Europe • Organic revenue growth (18%) in Scandinavia EBIT $54mn $47mn +15% • Margin improve
Slide 11: Minerals Division
Minerals Division Overview For personal use only H1 FY14 H1 FY13 Change • Geochemistry Revenue $232mn $345mn -33% • All markets remain weak – especially West Africa, Canada and South America EBITDA $75mn $137mn -45% • Global sample volumes stable for last four months EBIT $63mn $127mn -50% • Some lo
Slide 12: Industrial Division
Industrial Division Overview For personal use only H1 FY14 H1 FY13 Change • Asset Care • Scheduled outage inspection/maintenance Revenue $89mn $86mn +4% postponements – especially higher margin Power Generation work EBITDA $16mn $18mn -11% • Lower margins due to mobilization EBIT $14mn $16mn -13% pr
Slide 13: Energy Division
Energy Division For personal use only H1 FY14 H1 FY13 Change Overview • Coal Revenue $91mn $53mn +70% • Close to bottom of cycle – exploration activity to pick up in late CY14 EBITDA $27mn $18mn +50% • Australian production and export levels at record high EBIT $22mn $17mn +29% • Five new on-site pr
Slide 14: Divisional and Business Stream Structure
Divisional and Business Stream Structure Geochemistry For personal use only •Global Metallurgy Mineral Division •Australia & Americas Mine Site Environmental •Global •Global excluding Africa Inspection Food - Pharma •Europe, Africa, Asia & Life Science Division South America •Australia, Asia & Europ
Slide 15: Revenue Growth and Margin Strength
Revenue Growth and Margin Strength 1,500 35% For personal use only Core Labs ALS Revenue AUD$ million 1,200 30% EBITDA Margin ALS 900 25% 600 SGS 20% Bureau Veritas Intertek 300 15% Eurofins 0 10% FY09 FY10 FY11 FY12 FY13 H1 FY14 ALS Financial Year Ending March ALS Revenue ALS EBITDA Margin EBITDA M